Multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis: epidemiology and control. (Q36960077)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17914919%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

review article

1 reference

title

Multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis: epidemiology and control (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17914919%20AND%20SRC:MED&resulttype=core&format=json

Mycobacterium tuberculosis

8 January 2020

main subject

0 references

multiple drug resistance

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17914919%20AND%20SRC:MED&resulttype=core&format=json

Giovanni Battista Migliori

8 January 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17914919%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Rosella Centis

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17914919%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Mario Raviglione

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17914919%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

author name string

Daniela Cirillo

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17914919%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Enrico Girard

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17914919%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

publication date

1 October 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17914919%20AND%20SRC:MED&resulttype=core&format=json

Expert Review of Anti-infective Therapy

8 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17914919%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

volume

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17914919%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17914919%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

page(s)

857-871

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17914919%20AND%20SRC:MED&resulttype=core&format=json

Global surveillance for antituberculosis-drug resistance, 1994-1997. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance.

8 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.857

Global trends in resistance to antituberculosis drugs. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.857

Global incidence of multidrug-resistant tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.857

125 years after Robert Koch's discovery of the tubercle bacillus: the new XDR-TB threat. Is "science" enough to tackle the epidemic?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.857

Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.857

Evolution of drug resistance in Mycobacterium tuberculosis: clinical and molecular perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.857

Review: multidrug-resistant tuberculosis: public health challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.857

Fluoroquinolones, tuberculosis, and resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.857

The Rapid Development of Fluoroquinolone Resistance inM. tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.857

American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.857

Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.857

Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.857

Mutation of tlyA confers capreomycin resistance in Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.857

Molecular analysis of cross-resistance to capreomycin, kanamycin, amikacin, and viomycin in Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.857

Modeling the emergence of the 'hot zones': tuberculosis and the amplification dynamics of drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.857

HIV infection and multidrug-resistant tuberculosis: the perfect storm

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.857

Worldwide emergence of extensively drug-resistant tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.857

Extensively drug-resistant tuberculosis: 2 years of surveillance in Iran

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.857

Resistance of multidrug-resistant strains of Mycobacterium tuberculosis from the Archangel oblast, Russia, to second-line anti-tuberculosis drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.857

Extensively drug resistant tuberculosis: beware patients lost to follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.857

Extensively drug-resistant tuberculosis, Italy and Germany

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.857

XDR Tuberculosis — Implications for Global Public Health

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.857

Comparison of the recovery of Mycobacterium bovis isolates using the BACTEC MGIT 960 system, BACTEC 460 system, and Middlebrook 7H10 and 7H11 solid media.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.857

Rapid, automated, nonradiometric susceptibility testing of Mycobacterium tuberculosis complex to four first-line antituberculous drugs used in standard short-course chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.857

Multicenter laboratory validation of the BACTEC MGIT 960 technique for testing susceptibilities of Mycobacterium tuberculosis to classical second-line drugs and newer antimicrobials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.857

Rapid drug susceptibility testing of Mycobacterium tuberculosis using conventional solid media.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.857

Microscopic-observation drug-susceptibility assay for the diagnosis of TB

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.857

Bacteriophage-based assays for the rapid detection of rifampicin resistance in Mycobacterium tuberculosis: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.857

Resazurin microtiter assay plate testing of Mycobacterium tuberculosis susceptibilities to second-line drugs: rapid, simple, and inexpensive method

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.857

Rapid alternative methods for detection of rifampicin resistance in Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.857

Multicenter evaluation of the nitrate reductase assay for drug resistance detection of Mycobacterium tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.857

A new rapid and simple colorimetric method to detect pyrazinamide resistance in Mycobacterium tuberculosis using nicotinamide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.857

Colorimetric redox-indicator methods for the rapid detection of multidrug resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.857

Molecular diagnostics in tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.857

Detection of rifampin-resistant Mycobacterium tuberculosis in sputa by nested PCR-linked single-strand conformation polymorphism and DNA sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.857

Detection of rpoB mutations in Mycobacterium tuberculosis by biprobe analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.857

Direct detection of rifampin- and isoniazid-resistant Mycobacterium tuberculosis in auramine-rhodamine-positive sputum specimens by real-time PCR

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.857

Detection of rifampin resistance in Mycobacterium tuberculosis in a single tube with molecular beacons

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.857

A commercial line probe assay for the rapid detection of rifampicin resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.857

Use of the genotype MTBDR assay for rapid detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis complex isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.857

Use of genotype MTBDR assay for molecular detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis clinical strains isolated in Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.857

Rapid genotypic detection of rifampin- and isoniazid-resistant Mycobacterium tuberculosis directly in clinical specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.857

Evaluation of the GenoType MTBDRplus assay for rifampin and isoniazid susceptibility testing of Mycobacterium tuberculosis strains and clinical specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.857

Evaluation of a new line probe assay for rapid identification of gyrA mutations in Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.857

Peptide nucleic acid-mediated competitive PCR clamping for detection of rifampin-resistant Mycobacterium tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.857

Feasibility and cost-effectiveness of standardised second-line drug treatment for chronic tuberculosis patients: a national cohort study in Peru

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.857

The treatment of multidrug-resistant tuberculosis in Turkey

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.857

Community-based therapy for multidrug-resistant tuberculosis in Lima, Peru

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.857

Treatment experience of multidrug-resistant tuberculosis in Florida, 1994-1997.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.857

Treatment and Outcome Analysis of 205 Patients with Multidrug-resistant Tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.857

Outcome of multi-drug-resistant tuberculosis in France: a nationwide case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.857

New tuberculosis therapeutics: a growing pipeline

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.857

WHO's new Stop TB Strategy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.857

Progress of DOTS in global tuberculosis control

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.857

International standards for tuberculosis care

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.857

Tuberculosis infection control in resource-limited settings in the era of expanding HIV care and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.857

Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.857

Increasing transparency in partnerships for health--introducing the Green Light Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.857

Feasibility and cost-effectiveness of treating multidrug-resistant tuberculosis: a cohort study in the Philippines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.857

Cost-effectiveness of treating multidrug-resistant tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.857

Will tuberculosis become resistant to all antibiotics?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.857

Criteria for the control of drug-resistant tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.857

Mutation position and type of substitution in the beta-subunit of the RNA polymerase influence in-vitro activity of rifamycins in rifampicin-resistant Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.857

Altered NADH/NAD+ ratio mediates coresistance to isoniazid and ethionamide in mycobacteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.857

inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.857

ethA, inhA, and katG loci of ethionamide-resistant clinical Mycobacterium tuberculosis isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.857

Sequencing of the pncA gene in members of the Mycobacterium tuberculosis complex has important diagnostic applications: Identification of a species-specific pncA mutation in "Mycobacterium canettii" and the reliable and rapid predictor of pyrazinami

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.857

Emergence of ofloxacin resistance in Mycobacterium tuberculosis clinical isolates from China as determined by gyrA mutation analysis using denaturing high-pressure liquid chromatography and DNA sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.857

Emergence of fluoroquinolone-resistant tuberculosis in New York City.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.857

Cloning and nucleotide sequence of Mycobacterium tuberculosis gyrA and gyrB genes and detection of quinolone resistance mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.857

gyrA of ofloxacin-resistant clinical isolates of Mycobacterium tuberculosis from Hong Kong.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.857

21 January 2018

Identifiers

DOI

10.1586/14787210.5.5.857

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17914919%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1 reference